Diagnostic value of liver stiffness measurement combined with serum high-sensitivity C-reactive protein detection in HBV-related cirrhosis patients complicated with primary liver cancer.

Xiaoyan Liu; Lina MA; Xia Luo; Yuanyuan Tang; Shuaiwei Liu; Xiangchun Ding; Email: 13619511768 @163com

Return

Diagnostic value of liver stiffness measurement combined with serum high-sensitivity C-reactive protein detection in HBV-related cirrhosis patients complicated with primary liver cancer.

Author: Xiaoyan LIU ¹ ; Lina MA ¹ ; Xia LUO ¹ ; Yuanyuan TANG ¹ ; Shuaiwei LIU ¹ ; Xiangchun DING ² ; Email: 13619511768 @163.COM.
Author Information

1. Department of Infectious Disease, General Hospital of Ningxia Medical University, Yinchuan 750004, China.
2. Department of Infectious Disease, General Hospital of Ningxia Medical University, Yinchuan 750004, China
Publication Type:Journal Article
MeSH: Biomarkers; C-Reactive Protein; metabolism; Elasticity Imaging Techniques; Fibrosis; Hepatitis B, Chronic; complications; metabolism; Humans; Liver Cirrhosis; etiology; metabolism; virology; Liver Neoplasms
From: Chinese Journal of Oncology 2015;37(2):119-122
CountryChina
Language:Chinese
Abstract:
OBJECTIVEThe aim of this study was to explore the diagnostic value of liver stiffness measurement combined with serum high-sensitivity C-reactive protein detection in HBV-related cirrhosis patients complicated with primary liver cancer.
METHODSA total of 156 previously untreated chronic hepatitis B-related cirrhosis patients and 50 healthy subjects were included in this study. The 156 patients were divided into two groups: those with primary liver cancer (67 cases) and without liver cancer (89 cases). The 50 healthy subjects were considered as normal control group. Liver stiffness measurement (LSM) was conducted and serum high-sensitivity C-reactive protein (CRP) level was assayed in all the 156 patients and 50 normal individuals, and their measurement values were statistically compared and analyzed.
RESULTSThe LSM value was (39.72±29.05) kPa in the liver cancer patients, significantly higher than the (27.81±18.46) kPa in the cirrhosis alone patients and (4.25±0.74) kPa in the healthy controls (P<0.01 for both). Serum hs-CRP levels in the liver cancer patients was 5.81mg/L, significantly higher than 1.78 mg/L in the cirrhosis alone patients and 0.38mg/L in healthy controls, (P<0.01 for both). The higher the grade of LSM values was, the positive rate of CRP was higher in the cirrhosis patients complicated with primary liver cancer. In patients with LSM values ≥27.6 kPa, the serum CRP positive rate was 64.2% in patients with primary liver cancer, significantly higher than the 38.0% in patients with cirrhosis alone (P<0.01). In the 67 HBV-related cirrhosis patients complicated primary liver cancer, the LSM value and serum hs-CRP level in AFP-positive patients were (48.95±28.59) kPa and 4.91 mg/L, respectively, higher than those in the AFP-negative patients (28.64±26.83) kPa and 4.16 mg/L, but with a non-significant difference (P>0.05).
CONCLUSIONLiver stiffness measurement combined with serum high-sensitivity C-reactive protein detection may have potential diagnostic implications as a marker of primary liver cancer occurrence in patients with HBV-related cirrhosis.